Community pharmacies are valued on a multiple of adjusted EBITDA and on pence-per-item benchmarks. Goodwill dominates the price because the value is driven by the NHS contract and prescription volume, not the shop fittings or the retail stock. We explain the method transparently, help buyers and sellers understand what the numbers mean, and provide valuation support for transactions, disputes, and planning purposes. We stay strictly method-level: we do not assert a specific multiple without a cited market source, because an invented number here is the most damaging thing we could give a buyer or seller.
In most community pharmacy transactions, goodwill represents the majority of the purchase price. It reflects the NHS contract, the item volume, the location, and the competitive position, not the shop fitting or the till. Buyers and sellers who benchmark a pharmacy against normal retail business multiples start from the wrong premise.
Raw EBITDA in a pharmacy needs adjustment for owner remuneration (what the owner pays themselves versus a market-rate employed pharmacist), one-off costs, and the retrospective margin adjustments that come from Drug Tariff and Category M clawback volatility. An unadjusted figure will overstate or understate the true earnings capacity of the business.
Pence-per-item benchmarks are a real pricing yardstick used by specialist pharmacy brokers, but they move with market conditions and with the contract profile of the pharmacy. We describe the method and use the visitor's own volume inputs in the purchase affordability calculator, but we do not assert a specific benchmark without a cited market source. An invented figure here can lead a buyer to overpay or a seller to accept too little.
Where the pharmacy is acquired through a company, corporation tax relief on the purchased goodwill is restricted and only available in limited cases at fixed rates. Sellers face CGT on the goodwill gain, with BADR potentially available at 18% for 2026/27 on qualifying disposals up to the £1m lifetime limit. The valuation directly sets the gain on which the tax is calculated.
We explain what drives the adjusted EBITDA multiple and what the pence-per-item benchmark reflects, so buyers and sellers can interrogate a broker's number rather than just accept it. We use the purchase affordability calculator to let you model the arithmetic against your own inputs, not an asserted market figure.
Once a price is agreed, it must be allocated across goodwill, stock, fixtures, and property. Each has a different tax treatment, and the allocation affects the buyer's post-acquisition tax profile and the seller's gain computation. We advise on a defensible allocation that both sides can support.
We support buyers and sellers through the valuation mechanics at key moments: pre-sale planning, buyer due diligence, partner exit, probate, and divorce. Where a dispute requires an independent view of the method and the inputs, we can provide it within our accounting and tax advisory scope.
Tell us about your situation and we will reply within 24 hours.